For Whom the Cell Tolls? Intratumoral Treatment Links Innate and Adaptive Immunity
Ivan Marquez-Rodas, María Angela Aznar, Antonio Calles, Ignacio Melero
Intratumoral immunotherapy can potentially modulate the tumor microenvironment (TME) and potentiate the effects of concomitant or sequential systemic immunotherapies. Intratumoral administration of different Toll-like receptor agonists, including TLR4, can potentiate these effects through innate and adaptive immunity connection.
CITA DEL ARTÍCULO Clin Cancer Res. 2019 Feb 15;25(4):1127-1129. doi: 10.1158/1078-0432.CCR-18-2690. Epub 2018 Sep 27.